Rights and permissions
About this article
Cite this article
Enoxaparin a cost-effective choice for acute PE. Inpharma Wkly. 1509, 5 (2005). https://doi.org/10.2165/00128413-200515090-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200515090-00008